Peter J. Hulick, MD, MMSc
Peter J. Hulick is the Division Head and a medical geneticist at the NorthShore University HealthSystem Center for Medical Genetics and an Clinical Assistant Professor at the University of Chicago Pritzker School of Medicine.
Dr. Hulick completed his clinical medical genetics residency at Harvard Medical School where his clinical concentrations included connective tissue diseases such as Marfan syndrome and Ehlers-Danlos syndrome while also maintaining a general genetics clinic.
His research during his Harvard genetics training consisted of identifying potential biomarkers of kidney cancer through gene expression profiling of tumor cell lines and the development of a clinical assay to detect kidney cancer at an early stage. He also studied the biological function of the folliculin gene product which, when mutated, causes the kidney cancer predisposition syndrome Birt-Hogg-Dube. During his medical genetics residency, he graduated with a masters in medical science degree from the Harvard Medical Scholars in Clinical Science program which trains individuals for careers in clinical research.
Dr. Hulick received his undergraduate degree in biology from Northwestern University in Evanston, IL and his medical degree from Jefferson Medical College, in Philadelphia, PA. He completed an internal medicine residency at Mayo Clinic, Jacksonville, FL before pursuing his clinical medical genetics training in Boston. Dr. Hulick is board certified in Internal Medicine and Clinical Genetics.
His clinical interests, in addition to general genetic syndromes, include connective tissue disease, cardiovascular, and kidney cancer genetics.
Pablo V. Gejman, MD
Pablo V. Gejman is the Director of the Center for Genetics in Psychiatry at NorthShore and Professor of Psychiatry at the Feinberg School of Medicine, Northwestern University. He obtained an MD at the University of Buenos Aires and CONICET in Buenos Aires, Argentina. He completed his Residency in Psychiatry at Hadassah University Hospital, in Jerusalem, Israel.
Dr. Gejman was a Fellow at the University of Buenos Aires and CONICET from 1979-1982. From 1986-1993 Dr. Gejman was a John E. Fogarty Fellow in psychiatric research at the John E. Fogarty International Study for Advanced Study in the Health Sciences, at the National Institute of Mental Health (NIMH) and the Clinical Neurogenetics Branch (CNG), Intramural Research Program (IRP). During that time, he went on to become Senior Clinical Associate and Chief of the Unit on Molecular Clinical Investigation. From 1998-2003 he was Professor of Psychiatry at The Pritzker School of Medicine at the University of Chicago. He served as Director of the Schizophrenia Genetics Research Program (SGRP) in the Jules Knapp Medical Research Center at The University of Chicago, as well.
Dr. Gejman has built a nationally and internationally prominent research program with an emphasis on the genetics of schizophrenia. Dr. Gejman’s major fields of interest are clinical and biological inherited factors in major psychiatric disorders, molecular genetic diversity, and psychopharmacology and pharmacogenetics. He heads a cooperative international National Institute of Mental Heath funded study, the largest-ever funded by NIMH, to identify genes that lead to the development of schizophrenia.
Henry T. Lynch, MD
Henry T. Lynch is the Medical Advisor of the NorthShore Center for Medical Genetics.
He is Professor and Chairman of the Department of Preventive Medicine, Professor of Medicine, and the Director of the Creighton Cancer Center at Creighton University in Omaha, Nebraska. Dr. Lynch earned his MD at the University of Texas and trained in the internal medicine residency program at the University of Nebraska Medical Center.
Regarded by many as the father of cancer genetics, Dr. Lynch spent the majority of his career researching the hereditary basis of cancer and has published over 600 articles. He was the first to bring Hereditary Non-Polyposis Colorectal Cancer syndrome to general attention; the syndrome also bears his name as Lynch Syndrome. He has won numerous awards including the American Cancer Society Distinguished Service Award in 1992, the Sixth AACR (American Association for Cancer Research) American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention in 1997, the American Cancer Society 1997 Medal of Honor Clinical Research Award, The Susan G. Komen Breast Cancer Foundation 1998 Brinker International Award for Breast Cancer Clinical Research, the 2000 American Cancer Society Lecture Award given by the American Society of Clinical Oncology, and the Lifetime Achievement Award in Inherited Pancreatic Diseases awarded by The International Association of Pancreatology in 2001. Dr. Lynch has traveled the world, spreading knowledge of hereditary cancer and stimulating research investigations, and has mentored a generation of physicians and scientists in this field.
Shashanna Ndong, MD
Shashanna Ndong is a medical geneticist at the NorthShore University HealthSystem Center for Medical Genetics and a Clinical Educator at the University of Chicago School of Medicine.
Dr. Ndong completed her medical genetics training at the Icahn School of Medicine at Mount Sinai Medical Center in New York City. Her research included analysis of the effect of variants of uncertain significance in BRCA1 and BRCA2 on patient management decisions. She also participated in a retrospective analysis of the ophthalmologic findings in individuals with Fabry disease and studied the natural history of recurrent copy number variants. She completed residency at the University of Illinois at Chicago and is board certified in Internal Medicine and Pediatrics.
Her professional interests include congenital hearing loss, cardiovascular genetic disorders, and neurogenetic disorders in both adult and pediatric populations.
San Ming Wang, MD
San Ming Wang, MD, is Assistant Professor of Medicine in the Division of Genetics, and the Director of the Center for Functional Genomics, generously funded by the Daniel F. and Ada L. Rice Foundation. Dr. Wang received his undergraduate training in China, earned his MD degree at the Swiss Institute for Experimental Cancer Research, Switzerland, and was a postdoctoral fellow with Dr. Richard Morimoto at Northwestern University. He established himself as an independent investigator while working with Dr. Janet Rowley at the University of Chicago.
Dr. Wang has expertise in functional genomics studies. His scientific focus is to use whole genome approaches to identify genes involved in normal cell differentiation and use this information to delineate genes involved in cancers such as leukemia and breast cancer. He is a leading expert in applying a technique called SAGE (serial analysis of gene expression) to identify novel genes in human, mouse, Drosophila, and rice genomes.Dr. Wang’s research is funded by the National Human Genome Research Institute/NIH, the Department of Defense, the Mathers Foundation, and the Daniel F. and Ada L. Rice Foundation.